Drugs Flashcards
Ca gluconate
Increases the threshold of cardiac myocytes to restore cell excitability.
(HyperK tx)
0.5-1.0 ml/kg IV over 10-20 min
Furosemide
Loop diuretic. Blocks Na+K+2Cl- symporter in TAL of Henle to decrease Na, K, Cl, and water reabsorption.
(pulmonary edema, hyperK, hyperCa Tx)
3-5 mg/kg IV/IM/PO
Calcitonin
Osteoclast inhibiting Hormone
(HyperCa tx)
Calcitriol
Vitamin D analog
(Maintenance HypoCa tx)
Warfarin
Anticoagulant, inhibits vitamin K epoxide reductase (which prevents the activation of of active factor 2/7/9/10 and Proteins C and S)
Clopidogrel
Anti-platelet drug
Irreversibly blocks ADP binding to P2Y12 receptor on plt –> no activation of plt-plt receptor (GPaIIbIII)–> no fibrinogen binding or sustained aggregation.
3-4 mg/kg po sid
Aspirin
Anti-platelet drug.
COX-1 inhibitor –> suppression of TxA2. Irreversible fxl defect in plts.
1 mg/kg PO sid
cats: 5 mg po q72h
Dalteparin, Enoxaparin, Tinzaparin
Anticoagulant
Inhibition of factor X»_space; thrombin
Rivaroxaban, Alixaban, Endoxaban
Anticoagulant
Direct factor Xa inhibitors
Dabigatran
Anticoagulant
Direct thrombin inhibitor, reversible
Desmopressin
Prohemostatic. Synthetic ADH. Release of endo stores of vWF via V2 receptors. Also fVIII from plts, plasminogen from endo.
1-4 ug/kg
(vWD prophylactic)
Epsilon-aminocaproic acid, tranexamic acid
Antifibrinolytics.
Lysine analogues that block binding of plasminogen (stronger binding to plasminogen molecule), antiinflammatory through IL inhibition.
Protamine
Binds heparin
Aprotonin
Serine protease inhibitor. Basic trypsin inhibitor of bovine pancreas (Synthetic and Bovine)
Mannitol
Osmotic diuretic. Freely filtered by glomerulus, no reabsorption, results in an increase in osmotic pressure and water isn’t R. Also results in excretion of NaCl and solutes. (Proximal tubule) and loop of Henle.
Expands ECF–> nc renal blood flow –>inc medullary tonicity –> dec H2O reabsorption in distal tubule –> dec [Na] in ATL –> dec R of Na (passive!)
For kidney transplants: minimized arterial spasm, improves blood flow, protects against warm ischemia period
Bethanechol
Muscarinic, Cholinergic Agonist. Direct acting parasympathomimetic.
Ondansetron
Serotonin antagonist. Inhibits 5-HT3 receptors. Often used for vomiting due to chemotherapy tx.
Antiemetic
Maropitant
NK-1 Antagonist. Blocks neurokinin-1 (NK-1) receptors (NK-1, or substance p, stimulates emesis from emetic center)
Antiemetic
Pantoprazole/Omeprazole
Proton pump inhibitor, makes stomach less acidic
Mirtazapine
Tri-cyclic antidepressant: Blocks serotonin 5-HT3, 5-HT2, and 5-HT1 receptors Aplha-2 antagonist, inc intestinal motility, gastric emptying, colon transit times
Theophylline/Aminophylline
Bronchodilator
Phosphodiesterase inhibitor –> inc cAMP –> inc epinephrine. Relaxes smooth muscle of bronchi and pulmonary vasculature
Phenoxybenzamine
Alpha1 –adrenergic antagonist. (Alpha blocker) Binds to receptors to cause relaxation of urethral smooth muscle (internal sphincter). Same net effect of parasympathomimetic
Lidocaine
Na Channel Blocker (Class I), suppresses cardiac automaticity.
Antiarrhythmic, Local Anesthetic, Prokinetic
Erythromycin
Stimulates GI motility by stimulating motilin receptors to inc smooth muscle activity
Antibiotic, Prokinetic (Gastric emptying)
Ranitidine
Blocks H2 receptors of parietal cells Histamine (H2) antagonist.
Antacid and pro kinetic
Cisapride
Benzamide pro kinetic. Agonist of 5-HT4 receptor and antagonist at 5-HT3. May enhance release of Ach at myenteric plexus –> contraction of smooth muscle
Prokinetic (entire GIT)
Metoclopramide
Dopa antagonist (D2) in the CRTZ. Not understood, possibly stimulates 5-HT4 receptors or inc acetylcholine in GI tract. Anti dopa (inc cholinergic response in gastric sm muscle).Phenothiazines.
Antiemetic, Prokinetic (duodenal/jejunal peristalsis, amplitude of gastric contraction)
Azathioprine
antagonizes purine metabolism by causing breaks in DNA and RNA 2’ to incorporation into nucleic acids & termination of replication process (Purine analog that inhibits purine synthesis, leads to decreased lymphocyte proliferation)
Immunosuppressive
Cytosine arabinoside
cytarabine/cytosar
Inhibits DNA polymerase –> inhibits DNA synthesis (S phase)
Antineoplastic/Immunosuppressive
Cyclosporine
Inhibits normal T-cell transduction by blocking calcineurin phosphate activity, causing reduced cytokine genes (like IL-2)
Immunosuppressive
Tacrolimus
Inhibits normal T-cell transduction by blocking calcineurin phosphate activity, causing reduced cytokine genes (like IL-2)
Immunosuppressive
Mycophenolate
Inhibits the enzyme involved in purine synthesis, leads to decreased lymphocyte proliferation. Inhibits inosine monophosphate dehydrogenase (IMPDH) which is needed for de novo synthesis of purines in immune cells.
Immunosuppressive
Procarbazine
Abatacept/Belatacept
Selectively inhibit T cell activation
Immunosuppressive
Leflunomide
Inhibits pyrimidine synthesis and tyrosine kinase at high doses inhibits T and B cell proliferation, antibody production
Immunosuppressive
Pamidronate/Zoledronate
Inhibit boen resorption, inhibit osteoclast activity and induce osteoclast apoptosis
Bisphosphonates
Imatinib/Toceranib/Masitinib
Kinase inhibitor, c-kit tumors
Treatment of grade II or III cutaneous mast cell tumors, decreases blood supply (antiangiogenic by inhibiting RTK aka VEGF)
Cyclophosphamide
Alkylates N7 of guanine base of DNA, cytotoxic to rapidly dividing cells (cancer cells and bone marrow). Interferes with DNA replication and RNA translation
Alkylating chemotherapeutic, cell cycle independent
Lomustine
Vincristine/Vinblastine/Vinorelbine
Inhibits microtubules, anti-mitotic (specifically metaphase)
Vinca alkaloid chemotherapeutic, M phase
Paclitaxel